Cadila Healthcare Latest News
-
Total income of the company increased by 4.08% at Rs 3662.40 crore for Q1FY21Date:06-08-2020
-
Zydus Cadila has received USFDA’s tentative nod for Carbidopa, Levodopa extended-release capsulesDate:03-08-2020
-
This medication is used to treat the symptoms of Parkinson’s disease or Parkinson-like conditionsDate:03-08-2020
-
Cadila Healthcare has informed that the meeting of the Board of Directors of the Company will be held on Wednesday, August 5, 2020 to consider apart from other agenda items to approve the unaudited financial results...
Date:27-07-2020 -
Cadila Healthcare has informed that it has enclosed a copy of press release dated on July 23, 2020 titled ‘Zydus receives approval from USFDA to initiate clinical trials of Desidustat in cancer patients receiv...
Date:23-07-2020 -
Zydus Cadila has received approval from USFDA to initiate clinical trials of Desidustat in Chemotherapy Induced AnemiaDate:23-07-2020
-
Desidustat is expected to increase the red blood cell count and restore the erythropoietin levels to the normal levels in the cancer patients with CIADate:23-07-2020
-
The company had started clinical trials of its COVID-19 vaccine candidate with the first human dosingDate:20-07-2020
-
Cadila Healthcare has informed that it has enclosed a copy of press release dated July 18, 2020 titled ‘Zydus Cadila receives final approval from USFDA for Butalbital, Acetaminophen and Caffeine Tablets’...
Date:18-07-2020 -
This combination of medication is used to treat symptom complex of tension (or muscle contraction) headacheDate:18-07-2020
SEBI Registered: Investment Adviser - 
+91 20 6725 8333